4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-22-033391
SVP, Chief Financial Officer acquired 42,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coiante Scott M SVP, Chief Financial Officer | 2022-03-10 | Grant or award | +42,900 | 119,549 | D | ||
| Derivatives | |||||||
| Coiante Scott M SVP, Chief Financial Officer | 2022-03-10 | Grant or award · Stock Option (right to Buy) | +185,900 | 185,900 | D | ||
Loading xslF345X03/tm229119-3_4seq1.xml…